Supplements to Lower Glucose Levels: Evidence

Supplements to lower glucose levels are widely marketed in the UK, but understanding what the evidence actually shows is essential before considering them. Products such as berberine, cinnamon, chromium, magnesium, alpha-lipoic acid, and bitter melon are often positioned as natural alternatives to conventional diabetes treatment. None are licensed medicines in the UK, and none are recommended by NICE or Diabetes UK for glycaemic control. This article examines the clinical evidence, safety considerations, and potential interactions with prescribed diabetes medication, to help you make an informed decision alongside your GP or diabetes care team.

Which supplements are claimed to help lower blood glucose levels?

Commonly claimed glucose-lowering supplements include berberine, cinnamon, chromium, magnesium, alpha-lipoic acid, and bitter melon, but none are licensed medicines in the UK and none hold a regulated indication for treating or preventing diabetes.

Several supplements are commonly claimed to help lower blood glucose levels, including berberine, cinnamon, chromium, magnesium, alpha-lipoic acid, and bitter melon. These products are widely marketed in health food shops and online, often positioned as natural alternatives or additions to conventional diabetes management.

It is important to understand from the outset that none of these supplements are licensed medicines in the UK. The MHRA regulates food supplements as food products rather than medicines, and none of the named substances hold a licensed indication for the treatment or prevention of diabetes under UK medicines law. This means they have not undergone the rigorous pre-market efficacy and safety evaluation required of licensed medicines.

Berberine, a compound extracted from several plants, has attracted particular attention due to its proposed effects on insulin sensitivity and glucose metabolism. Cinnamon extract is frequently cited, with some researchers suggesting it may influence insulin receptor activity. Chromium is an essential trace mineral thought to play a role in carbohydrate metabolism, and magnesium deficiency has been associated with impaired insulin signalling in some studies. Alpha-lipoic acid is an antioxidant studied in the context of diabetic neuropathy and glucose regulation. Bitter melon, used in traditional medicine across parts of Asia and Africa, contains compounds that may have insulin-like activity.

While these mechanisms are biologically plausible, a plausible mechanism does not confirm clinical effectiveness or safety in humans. Quality, purity, and dose can vary significantly between brands, and the Food Standards Agency (FSA) advises consumers to exercise caution when choosing food supplements.^[2][3]

Anyone considering these products should discuss them with their GP or diabetes care team before starting, particularly if they are already taking prescribed medication. This is especially important for people who are pregnant, planning a pregnancy, or breastfeeding, as several of these supplements (including berberine and bitter melon) are generally not recommended during pregnancy or breastfeeding due to insufficient safety data.^[14] Supplements should never be used as a substitute for prescribed diabetes treatment.

What does the evidence actually say about glucose-lowering supplements?

Clinical evidence for glucose-lowering supplements is limited and inconsistent; NICE and Diabetes UK do not recommend any supplement as a primary or adjunctive glucose-lowering intervention.

The clinical evidence for glucose-lowering supplements is generally limited, inconsistent, and insufficient to support their routine use as a substitute for prescribed treatment. Most studies are small, short in duration, and vary considerably in the quality of the supplement used, the dose administered, and the population studied. NICE guidance on type 2 diabetes in adults (NG28) does not recommend any dietary supplement as a primary or adjunctive glucose-lowering intervention, and Diabetes UK similarly does not endorse supplements for glycaemic control.^[4]

Berberine has perhaps the most studied profile among these supplements. Some small randomised controlled trials have reported modest reductions in fasting blood glucose and HbA1c. Certain of these trials have drawn comparisons with metformin, but such comparisons are limited by small sample sizes, short follow-up periods, and significant methodological weaknesses; they do not establish berberine as equivalent to metformin, and no large, well-designed UK or European trial has validated berberine as a clinical treatment for diabetes. Systematic reviews of the available evidence note these limitations explicitly.

Cinnamon studies have produced mixed results. Some trials report small reductions in fasting glucose, while others show no meaningful effect; systematic reviews and Cochrane analyses have not found consistent evidence of clinically significant benefit.

Chromium supplementation has shown some benefit in people with documented chromium deficiency, but evidence for benefit in those with adequate chromium levels is weak.^[9][10] Magnesium supplementation may be relevant where a confirmed deficiency exists, but supplementing without a documented deficiency is not supported by robust evidence. Alpha-lipoic acid has shown some promise in reducing markers of oxidative stress, but its effect on blood glucose control in humans remains uncertain.

In summary, while some supplements show early signals of potential benefit, none have the evidence base required to be recommended as a reliable glucose-lowering intervention. Patients should treat marketing claims with caution and rely on evidence-based treatments recommended by their healthcare team.

Are these supplements safe to take alongside diabetes medication?

Taking glucose-lowering supplements alongside prescribed diabetes medication, particularly insulin or sulfonylureas, carries a real risk of hypoglycaemia and potential drug interactions, so always consult your GP or pharmacist first.

Taking glucose-lowering supplements alongside prescribed diabetes medication carries a real risk of hypoglycaemia (low blood sugar). The risk is greatest with medicines that have a high intrinsic hypoglycaemia potential, particularly insulin and sulfonylureas (such as gliclazide or glibenclamide). Metformin alone, and incretin-based therapies used as monotherapy, carry a lower intrinsic risk of hypoglycaemia; however, if a supplement genuinely lowers blood glucose, even modestly, combining it with any glucose-lowering medicine could push glucose levels lower than intended, and the overall risk depends on the combination of treatments a person is taking. Anyone adding a supplement to their regimen should discuss this with their GP or pharmacist and consider more frequent blood glucose monitoring.

For reference, semaglutide (available as Ozempic and Wegovy) is a GLP-1 receptor agonist, while tirzepatide (Mounjaro) is a dual GIP and GLP-1 receptor agonist; both are incretin-based therapies.^[11][12] Their UK Summaries of Product Characteristics (available via the Electronic Medicines Compendium) describe their hypoglycaemia profiles and relevant interactions.

Berberine in particular has been associated with inhibition of cytochrome P450 enzymes involved in drug metabolism, which may alter the plasma concentration of co-administered medicines. This could potentially affect not only diabetes drugs but also statins, anticoagulants, and antihypertensives. Authoritative interaction references such as Stockley's Herbal Medicines Interactions document some of these concerns, though the clinical significance of individual interactions varies. Anyone taking prescribed medication should consult their GP or pharmacist before adding berberine or any other supplement to their routine.

Cinnamon, chromium, and magnesium are generally considered lower risk in terms of drug interactions, but they are not without concern. High-dose cinnamon (particularly cassia cinnamon) contains coumarin, which may affect liver function with prolonged use. Chromium in large doses has been associated with kidney and liver toxicity in isolated case reports.^[18][19]

Supplements sold in the UK are regulated as food products rather than medicines and are not subject to the same rigorous pre-market safety and efficacy testing as licensed medicines. Patients managing diabetes should always inform their GP or diabetes nurse of any supplements they are taking, and should never reduce or stop prescribed medication in favour of a supplement without medical advice.

What side effects and risks should you know about?

Side effects vary by supplement but commonly include gastrointestinal symptoms; berberine and bitter melon are not recommended in pregnancy, and high-dose cassia cinnamon contains coumarin, which may cause liver damage with prolonged use.

Glucose-lowering supplements can cause a range of side effects, and the risk profile varies depending on the specific supplement, the dose, and the individual taking it. Gastrointestinal symptoms are among the most commonly reported effects across several of these products. Berberine frequently causes nausea, diarrhoea, constipation, and abdominal discomfort, particularly at higher doses.

Bitter melon has been associated with gastrointestinal upset and, in some reports, hypoglycaemic episodes. It is generally not recommended in pregnancy.

Alpha-lipoic acid is generally well tolerated at standard doses but can cause nausea and skin rash. High-dose magnesium supplementation can cause diarrhoea and, in people with impaired kidney function, may accumulate to harmful levels. Chromium supplements have been associated with headaches, sleep disturbance, and, at very high doses, potential kidney and liver toxicity.

High-dose cassia cinnamon contains coumarin, which the FSA has highlighted as a substance that may cause liver damage with prolonged high intake. The FSA advises that people who consume cinnamon regularly as a supplement should be aware of this risk and avoid very high doses.

People who are pregnant, planning a pregnancy, or breastfeeding should avoid these supplements unless specifically advised otherwise by a clinician. Berberine and bitter melon in particular are generally not recommended during pregnancy or breastfeeding due to insufficient safety data.^[14]

From a patient safety perspective, the following situations should prompt contact with a GP or diabetes care team:

• Symptoms of hypoglycaemia, including shakiness, sweating, confusion, or palpitations, particularly if taking prescribed glucose-lowering medication. In the UK, hypoglycaemia is generally defined as a blood glucose level below 4.0 mmol/L. If you experience symptoms, follow the guidance from your diabetes team or the NHS on treating low blood sugar promptly with a fast-acting carbohydrate.

• Persistent gastrointestinal symptoms after starting a supplement

• Any new or unexplained symptoms that coincide with starting a supplement

• Concerns about interactions with existing prescribed medicines

If you experience a severe hypoglycaemic episode that does not resolve with oral glucose, call 999 immediately. For non-urgent concerns about a supplement, contact your GP or call NHS 111 for advice.

Suspected adverse reactions to supplements can be reported to the MHRA via the Yellow Card scheme at yellowcard.^[20][21]mhra.gov.uk. This reporting helps the MHRA monitor the safety of products available in the UK and contributes to national pharmacovigilance. Reporting is open to both patients and healthcare professionals.

Scientific References

1. Nutrition legislation information sheet.
2. Food supplements: guidance for consumers.
3. Food supplements guidance.
4. Type 2 diabetes in adults: management (NG28).
5. Diabetes UK evidence-based nutrition guidelines for the prevention and management of diabetes.
6. Effects of cinnamon supplementation on metabolic biomarkers in individuals with type 2 diabetes: a systematic review and meta-analysis.
7. The effect of cinnamon supplementation on glycemic control (Moridpour AH et al.).
8. Comparative effectiveness of six herbs in the management of glycemic status of type 2 diabetes mellitus patients: A systematic review and network meta-analysis.
9. Effect of Chromium Supplementation on Blood Glucose (Zhao F et al.).
10. Effects of chromium supplementation on glycemic control in patients with type 2 diabetes: a systematic review and meta-analysis.
11. GLP-1 medicines for weight loss and diabetes: what you need to know.
12. Semaglutide | Drugs | BNF.
13. The enhancement of cardiotoxicity that results from inhibition of CYP3A4 by berberine in combination with statins (Feng P et al.).
14. Comprehensive Analysis of berberine and protoberberinoids.
15. Effects of Berberis vulgaris and its active constituent berberine on cytochrome P450: a review.
16. Low blood sugar (hypoglycaemia).
17. Hypoglycaemia | Treatment summaries | BNF.
18. Chromium picolinate toxicity (Cerulli J et al.).
19. Chromium: toxicological overview.
20. Herbal medicines: report suspected adverse reactions to the Yellow Card Scheme.
21. Adverse reactions to drugs | Medicines guidance | BNF.

Frequently Asked Questions